Acupuncture Versus Laser Acupuncture for Carpal Tunnel Syndrome
Institutional Review Board of Kuang Tien General Hospital
1 other identifier
interventional
150
1 country
1
Brief Summary
Carpal tunnel syndrome (CTS) results from the entrapment neuropathy of median nerve at the wrist, and most cases are idiopathic. So far, there are many treatments were developed (Surgical decompression, local injection of steroids, Wrist splints) but they are not fully satisfactory, other treatment modalities need to be further evaluated. Both Acupuncture and laser acupuncture treatments for CTS have been reported. However, those studies still lack associated evidence to evaluate the efficacy of acupuncture and laser acupuncture. The object of the study is to investigate the efficacy of acupuncture compared with laser acupuncture in patients with mild-to-moderate carpal tunnel syndrome (CTS). Nerve conduction studies (NCS) and global symptom score (GSS) assessment will apply to measure objective changes in this randomized, controlled study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2021
CompletedFirst Submitted
Initial submission to the registry
March 24, 2021
CompletedFirst Posted
Study publicly available on registry
April 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2022
CompletedNovember 30, 2021
November 1, 2021
1.2 years
March 24, 2021
November 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Global symptom score
rated symptoms(Pain ,Numbness, paresthesia, Nocturnal awakening) from 0(no symptoms) to 10 (very severe symptoms)
Change from Baseline GSS at 2 weeks
Global symptom score
rated symptoms(Pain ,Numbness, paresthesia, Nocturnal awakening) from 0(no symptoms) to 10 (very severe symptoms)
Change from Baseline GSS at 4 weeks
Secondary Outcomes (1)
Nerve conduction studies
Change from Baseline nerve conduction studies (NCS) at 4 weeks
Study Arms (3)
Laser Acupuncture Group
EXPERIMENTALAcupuncture point: PC-6 and PC-7 laser pen is vertical to the points and with the pen at a distance of 0.5- cm from the skin., every point is treated for 1 min administrated over 4 weeks (2 sessions/wk)
Manual Acupuncture Group
ACTIVE COMPARATORAcupuncture point: PC-6 and PC-7 Responses elicited: de qi sensation Manual: twirling with lifting-thrusting method stimulation Needles retained for 30 min Needle type: C\&G, gauge and size: 0.25x40mm
Sham Laser Acupuncture Group
SHAM COMPARATORAcupuncture point: PC-6 and PC-7 Sham laser pen is vertical to the points and with the pen at a distance of 0.5- cm from the skin., every point is treated for 1 min administrated over 4 weeks (2 sessions/wk)
Interventions
400 mW, near-infrared, continuous wavelength, 810 nm. about 24J/cm2
This laser pen is the same device with a red light was pasted on the acu-points in the same way, using the same protocol as for the active laser stimulation, but the laser apparatus was not switched on.
Eligibility Criteria
You may qualify if:
- CTS diagnosis was based on the presence of at least one of the following symptoms
- numbness, tingling pain, or paresthesia in the median nerve distribution
- precipitation of these symptoms by repetitive hand activities, which could be relieved by resting, rubbing, and shaking the hand
- nocturnal awakening by such sensory symptoms.
- The diagnosis was often supported by a positive Tinel sign Confirmed by the presence of one or more of the following standard electrophysiologic criteria
- (1) prolonged distal motor latency (DML) to the abductor pollicis brevis (APB) (abnormal Z4.7 ms, stimulation over the wrist, 8 cm proximal to the active electrode) (2) prolonged antidromic distal sensory latency (DSL) to the second digit (abnormal Z3.1 ms;stimulation over the wrist, 14 cm proximal to the active electrode) (3) prolonged antidromic wrist-palm sensory nerve conduction velocity (W-P SNCV) at a distance of 8 cm (W-P SNCV, abnormal \<45 m/s).9-
You may not qualify if:
- Symptoms occurring less than 3 months before the study (to exclude patients who might have spontaneous resolution of symptoms)
- severe CTS that had progressed to visible muscle atrophy
- clinical or electrophysiologic evidence of accompanying conditions that could mimic CTS or interfere with its evaluation, such as cervical radiculopathy, proximal median neuropathy, or significant polyneuropathy
- evidence of obvious underlying etiologic factors of CTS such as diabetes mellitus, rheumatoid arthritis, hypothyroidism (acromegaly), pregnancy, alcohol abuse or drug usage (steroids or drugs acting through the central nervous system), and suspected malignancy or inflammation or autoimmune disease documented as underlying causes of CTS
- cognitive impairment interfering with the subject's ability to follow instructions and describe symptoms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kuang Tien Genreal Hospital
Taichung, 402, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chun-Pai Yang, PhD
Kuang Tien Genreal Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- TCM department
Study Record Dates
First Submitted
March 24, 2021
First Posted
April 2, 2021
Study Start
March 10, 2021
Primary Completion
May 20, 2022
Study Completion
June 20, 2022
Last Updated
November 30, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share